Publisher’s Notice: MDPI stays neutral with regards to jurisdictional statements in released maps and institutional affiliations.Abstract Tirzepatide is a new molecule effective at controlling glucose blood amounts by combining the twin agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. GI… Read More